Skip to main content

Table 1 Correlation between the expression of P300 and clinicopathologic features in nasopharyngeal carcinomas

From: High expression of p300 is linked to aggressive features and poor prognosis of Nasopharyngeal Carcinoma

  

P300 protein

 

All cases

Low expression

High expression

P value*

Sex

   

0.560

Female

59

25 (42.4%)

34 (57.6%)

 

Male

150

57 (38.0%)

93 (62.0%)

 

Age at diagnosis (years)

   

0.583

≤ 45

89

33 (37.1%)

56 (62.9%)

 

> 45

120

49 (40.8%)

71 (59.2%)

 

Histological classification (WHO)

   

0.363

Type II

54

24 (44.4%)

30 (55.6%)

 

Type III

155

58 (37.4%)

97 (62.6%)

 

T classification

   

0.000

1

26

19 (73.1%)

7 (26.9%)

 

2

68

37 (54.4%)

31 (45.6%)

 

3

69

17 (24.6%)

52 (75.4%)

 

4

46

9 (19.6%)

37 (80.4%)

 

N classification

   

0.024

0

40

23 (57.5%)

17 (42.5%)

 

1

96

34 (35.4%)

62 (64.6%)

 

2

51

15 (29.4%)

36 (70.6%)

 

3

22

6 (27.3%)

16 (72.7%)

 

Distant metastasis

   

0.021

0

158

69 (43.7%)

89 (56.3%)

 

1

51

13 (25.5%)

38 (74.5%)

 

Clinical stage

   

0.000

I

10

8 (80.0%)

2 (20.0%)

 

II

55

37 (67.3%)

18 (32.7%)

 

III

83

23 (27.7%)

60 (72.3%)

 

IV

61

14 (23.0%)

47 (77.0%)

 
  1. *Chi-square test; WHO, World Health Organization.